全文获取类型
收费全文 | 40193篇 |
免费 | 3517篇 |
国内免费 | 1475篇 |
专业分类
耳鼻咽喉 | 1370篇 |
儿科学 | 878篇 |
妇产科学 | 432篇 |
基础医学 | 2951篇 |
口腔科学 | 1577篇 |
临床医学 | 4719篇 |
内科学 | 6472篇 |
皮肤病学 | 1137篇 |
神经病学 | 1697篇 |
特种医学 | 1760篇 |
外国民族医学 | 2篇 |
外科学 | 3524篇 |
综合类 | 7270篇 |
一般理论 | 4篇 |
预防医学 | 5083篇 |
眼科学 | 900篇 |
药学 | 2721篇 |
32篇 | |
中国医学 | 1769篇 |
肿瘤学 | 887篇 |
出版年
2024年 | 39篇 |
2023年 | 802篇 |
2022年 | 1251篇 |
2021年 | 1810篇 |
2020年 | 1963篇 |
2019年 | 1386篇 |
2018年 | 1233篇 |
2017年 | 1382篇 |
2016年 | 1486篇 |
2015年 | 1389篇 |
2014年 | 2793篇 |
2013年 | 2897篇 |
2012年 | 2605篇 |
2011年 | 2740篇 |
2010年 | 2234篇 |
2009年 | 2096篇 |
2008年 | 2001篇 |
2007年 | 2036篇 |
2006年 | 1779篇 |
2005年 | 1599篇 |
2004年 | 1281篇 |
2003年 | 1152篇 |
2002年 | 982篇 |
2001年 | 937篇 |
2000年 | 747篇 |
1999年 | 569篇 |
1998年 | 528篇 |
1997年 | 415篇 |
1996年 | 310篇 |
1995年 | 400篇 |
1994年 | 328篇 |
1993年 | 221篇 |
1992年 | 240篇 |
1991年 | 225篇 |
1990年 | 180篇 |
1989年 | 178篇 |
1988年 | 156篇 |
1987年 | 150篇 |
1986年 | 120篇 |
1985年 | 106篇 |
1984年 | 84篇 |
1983年 | 50篇 |
1982年 | 49篇 |
1981年 | 33篇 |
1980年 | 29篇 |
1979年 | 44篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1976年 | 28篇 |
1975年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
《Indian journal of medical microbiology》2022,40(4):480-484
BackgroundInvasive Fungal Diseases (IFD), account for high morbidity and mortality in immunocompromised and seriously ill patients worldwide. Early, faster and accurate diagnosis with timely and appropriate patient management is critical for improved patient outcome and antifungal stewardship. Clinical/radiological presentations in IFD are non-specific and microscopy/culture based tests have low sensitivity and long turnaround time. Biomarkers have clinical utility for diagnosing IFD but their interpretation is not straight forward.ObjectivesThis review discusses the salient characteristics, clinical usefulness and limitations of common biomarkers such as Galactomannan (GM), 1–3, β D glucan (βDG), mannan, anti-mannan antibody (Mn/antiMn), Cryptococcal antigen test (CrAg), Nucleic Acid Amplification (NAA) tests and next generation sequencing for diagnosing IFD.ContentsFungal biomarkers are useful adjuncts as screening and diagnostic tools for IFD and are much more suited for ‘ruling out’ rather than ‘ruling in’ disease. GM, NAA tests are promising biomarkers for screening of invasive Aspergillosis in high risk asymptomatic patients who are not on antifungal therapy and for diagnosis of breakthrough infections in symptomatic patients. 1–3, β D glucan has limitations both as a ‘rule in’ and ‘rule out’ test and is useful in only specific clinical settings. Two consecutive positive 1-3-βDG tests or combined positivity with GM increases its specificity. Mn/antiMn, T2Candida nano diagnostic panel are promising candidates for diagnosing invasive candidiasis. Combining two or more biomarkers improves the sensitivity for prompt initiation of antifungal therapy and the negative predictive value for suspension of empirical treatment.Serum CrAg test is a good ‘rule in’ rather than a ‘rule out’ test in immunocompetent patients but has good diagnostic accuracy in immunocompromised patients. Detection of single nucleotide polymorphisms by next generation sequencing is useful for fungal characterization and identification of host determinants responsible for increased susceptibility to fungal infections but is still in experimental stages. 相似文献
3.
4.
《Arab Journal Of Gastroenterology》2022,23(1):58-60
A liver abscess is identified as a rare extraintestinal manifestation of Crohn’s disease, with an incidence of approximately 150 in 100,000 patients with this condition. In many of these patients, infectious causes are identified, and the patient’s condition is often noted to improve with antibiotics. An aseptic abscess (AA) is an increasingly recognized entity, especially in patients with inflammatory bowel disease, where repetitive evaluations to identify the infectious cause are futile. The average age of diagnosis for an AA is 29 years. The most common site is the spleen, followed by the lymph nodes and then the liver. In this study, we present a unique case of extensive aseptic liver abscesses extending into the pleural cavity in a young patient with Crohn’s disease. 相似文献
6.
7.
《Drug discovery today》2022,27(6):1724-1732
The enactment of orphan drug-specific legislation pioneered by the USA was subsequently followed by many regions, including the European Union (EU), Australia, Japan, and Taiwan. Here, we discuss the associated regulations established and their impacts in the aforementioned regions, which are among the first with frameworks specific for orphan drugs. Varied scopes of rare diseases or orphan drugs, diverse incentives, and heterogeneous types of reimbursement systems imply the prioritization of the agencies concerned. The numbers of designated and approved drugs reflect the impact of the regulatory and reimbursement frameworks. A comparison of the frameworks and their impact in the respective regions could provide valuable information for developing and improving related frameworks for countries worldwide. 相似文献
8.
Bacterial keratitis continues to be one of the leading causes of corneal blindness in the developed as well as the developing world, despite swift progress since the dawn of the “anti-biotic era”. Although, we have expeditiously developed our understanding about the different causative organisms and associated pathology leading to keratitis, extensive gaps in knowledge continue to dampen the efforts required for early and accurate diagnosis, and management in these patients, resulting in poor clinical outcomes. The ability of the causative bacteria to subdue the therapeutic challenge stems from their large genome encoding complex regulatory networks, variety of unique virulence factors, and rapid secretion of tissue damaging proteases and toxins.In this review article, we provide an overview of the established diagnostic techniques and therapeutics for keratitis caused by various bacteria. We extensively report the recent in-roads through novel tools for accurately diagnosing mono- and poly-bacterial corneal infections. Furthermore, we outline the recent progress by our groups and others in understanding the sub-cellular genomic changes that lead to antibiotic resistance in these organisms. Finally, we discuss in detail, the novel therapies and drug delivery systems in development for the efficacious management of bacterial keratitis. 相似文献
9.
胶质淋巴系统是一个主要由星形胶质细胞水通道蛋白4介导的依靠动脉、静脉周围血管间隙的脑脊液-脑组织液交换流动的系统,是阿尔茨海默病、脑卒中、帕金森病、失眠、抑郁症等脑病的共同特征,是一条新的脑代谢途径,可以清除包括β-淀粉样蛋白、乳酸在内的代谢产物。本文综合分析了全球有关胶质淋巴系统在脑部疾病的研究,得出:胶质淋巴系统可能为神经退行性疾病等发病机制和诊治策略研究带来新视角;胶质淋巴系统有望为一些脑部疾病诊断提供新的有效证据;胶质淋巴系统可能是脑部疾病治疗给药方式的新途径。 相似文献
10.
目的 观察超声引导下关节腔内注射重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白(益赛普)治疗血友病性关节病(HA)的价值。方法 回顾性分析32例接受超声引导下穿刺关节腔注射益赛普的HA患者,对比观察治疗前及治疗后1个月血友病关节健康评分(HJHS)、视觉模拟评分(VAS),以及超声所示目标关节增生滑膜厚度、血流信号、Melchiorre及中国早期血友病性关节病超声检测(HEAD-US-C)评分,评估其治疗价值。结果 对32例均成功完成超声引导下穿刺关节腔及腔内注射益赛普,共对18例膝关节、7例肘关节及7例踝关节进行治疗。术后未出现感染、出血等并发症。治疗后1个月,目标关节HJHS、VAS、Melchiorre评分、HEAD-US-C评分及增生滑膜最大厚度、平均厚度、血流信号均低于治疗前(P均<0.01)。结论 超声引导下关节腔内注射益赛普治疗HA安全、有效。 相似文献